AI
ASMB icon

Atom Investors’s Assembly Biosciences ASMB Stock Holding History

Atom Investors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,257
Closed -$1.47M – 247
2020
Q4 		$1.47M Buy
20,257
+8,681
+75% +$1.02M 0.15% 160
2020
Q3 		$2.28M Sell
11,576
-502
-4% -$126K 0.22% 112
2020
Q2 		$3.38M Buy
12,078
+828
+7% +$193K 0.22% 85
2020
Q1 		$2M Buy
+11,250
New +$2.41M 0.18% 111

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Atom Investors's ASMB Position: Q1 2021 in Review

Atom Investors sold out of Assembly Biosciences (ASMB) in Q1 2021, closing a stake of 20,257 shares — an estimated $1.47M sold.

Atom Investors first reported a position in ASMB in Q1 2020 and held it in 4 quarters. The position peaked at $3.38M in Q2 2020. 107 funds tracked by Wall St. Rank hold ASMB as of Q1 2021.

  • Atom Investors reported no remaining Assembly Biosciences position as of Q1 2021 after selling out during the quarter.
  • Atom Investors sold 20,257 Assembly Biosciences shares in Q1 2021, an estimated $1.47M.
  • Atom Investors first reported a position in Assembly Biosciences in Q1 2020 and held it in 4 quarters.
  • Atom Investors's Assembly Biosciences position peaked at $3.38M in Q2 2020.
  • 107 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2021.

Based on Atom Investors's 13F filing for Q1 2021, filed 17 May 2021.